Ischemic stroke is an important cause of morbidity and mortality in cancer patients. The
underlying mechanisms linking cancer and stroke are not completely understood. Long …

Single cell analysis of cancer cell transcriptome may shed a completely new light on cancer-
associated thrombosis (CAT). CAT causes morbid, and sometimes lethal complications in …

Introduction Limited data exist on the risk of venous and arterial thromboembolisms (VTE
and ATE) in patients receiving cetuximab plus chemotherapy. We aimed to determine the …

Thromboembolic complications, including venous thromboembolism (VTE) and arterial
thromboembolism (ATE), increase mortality and morbidity, and delay treatment in patients …

Opinion Statement Cancer-associated thrombosis (CAT) has been identified as the second
most prevalent cause of death after cancer itself. Moreover, the risk of thrombotic events in …

Background Immune checkpoint inhibitors (ICIs) have revolutionized the management of
cancers. The risk factors and pathophysiological mechanisms of venous thromboembolic …

Background Continuously improving cancer-specific survival puts a growing proportion of
cancer patients at risk of major adverse cardiovascular events (MACE), but tailored tools for …

Venous thromboembolism (VTE) is a common and potentially life-threatening complication
in patients with cancer. Both cancer and its treatments increase the risk of developing VTE …

The correlation between cancer and venous thromboembolism (VTE) is solid, whereas the
knowledge about cancer-related arterial thromboembolism (ATE) still needs a deeper …

Background: The aim of this study was to develop a nomogram model in combination with
thromboelastography (TEG) to predict the development of venous thromboembolism (VTE) …